Peptide Bioavailability
Peptide Bioavailability is the fraction and rate at which an administered peptide reaches its site of action in the systemic circulation or target tissue, distinguishing it from other pharmacokinetic parameters by specifically quantifying the therapeutically available portion of the peptide following delivery.
38
Publications
2.5K
Citations
213
Authors
74
Institutions
Publications per year
2017–2026
14
Parents
38
Bioavailability of Bioactive Peptides
Maira Rubí Segura Campos, Luis Chel‐Guerrero, David Betancur‐Ancona et al. · Food Reviews International · 2011 · 214 citations
Pharmacy, Nutrition, Pharmacology +16
Enzymatic barriers to peptide and protein absorption.
Vincent H. L. Lee · PubMed · 1988 · 210 citations
1–5 of 38
213
2
h-index
2
h-index
2
h-index
2
h-index
Rutgers, The State University of New Jersey, United States
2 publications · 103 citations
2
h-index
1–5 of 213
74

University of Ottawa
Ottawa, Canada
2 h-index
4 publications
645 citations
Medigene (Germany)
Planegg, Germany
2 h-index
9 publications
477 citations

University of Life Sciences in Lublin
Lublin, Poland
2 h-index
5 publications
237 citations
Center for Drug Evaluation and Research
Silver Spring, United States
2 h-index
8 publications
368 citations
Rutgers, The State University of New Jersey
New Brunswick, United States
2 h-index
9 publications
531 citations
Johnson University
Knoxville, United States
1 h-index
2 publications
130 citations
Erasmus MC
Rotterdam, The Netherlands
1 h-index
2 publications
234 citations
Ferris State University
Big Rapids, United States
1 h-index
1 publications
38 citations
1–8 of 74
4 publications · 158 citations
4
h-index
3 publications · 248 citations
3
h-index
2 publications · 311 citations
2
h-index
2 publications · 93 citations
2
h-index
Repository · 2 publications · 225 citations
2
h-index
1–5